Analyst Confidence Remains High for IBM’s Strategic Direction
Published on 01/09/2026 at 10:45 | Redaktion boerse-global.de
Market experts continue to express strong confidence in International Business Machines Corp. (IBM), citing its robust operational health and a pivotal strategic acquisition. This optimism was underscored on Thursday when analysts at Oppenheimer reaffirmed their ‘Outperform’ rating on the equity, maintaining a price target of $360. This projection implies a potential upside of approximately 19% from current trading levels. The bullish outlook is largely predicated on anticipated acceleration in IBM’s software segment by 2026, fueled by the planned $11 billion acquisition of Confluent.
The prospective Confluent deal is viewed as a central catalyst for future growth. IBM aims to leverage the acquisition to build a unified platform for real-time AI infrastructure within hybrid cloud Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
